Dr Arnab Basu, chief executive of (), tells Proactive's Andrew Scott their medical division has won two contracts worth a combined US$1mln.
Basu says an equipment manufacturing customer's placed a US$700,000 order for their cadmium zinc telluride (CZT) detectors to be used in nuclear medicine.
Meanwhile in the bone mineral densitometry market they've received a repeat contract of $340,000 for CZT-based detectors.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...
FOR OUR FULL DISCLAIMER CLICK HERE